Back

Journal of Antimicrobial Chemotherapy

19 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Efficacy and safety of newer antibiotics versus generic antibiotics for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: a systematic review and meta-analysis of randomized controlled trials
2026-02-12 infectious diseases 10.64898/2026.02.11.26345978
#1 (11.0%)
Show abstract

BackgroundHospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), particularly those caused by multi-drug resistant organisms (MDROs), often require newer antibiotic treatment. The efficacy and safety of newer antibiotics compared to generic antibiotics in randomized controlled trials (RCTs) have not been evaluated before. MethodsIn this systematic review, we searched RCTs in the United States National Library of Medicine (PubMed), Cochrane Central Reg...

2
Global pricing of AWaRe (Access, Watch, Reserve) antibiotics: implications of the UNGA-AMR 70% Access target on national pharmaceutical expenditure
2026-02-14 health economics 10.64898/2026.02.12.26346187
#1 (3.7%)
Show abstract

BackgroundThe United Nations General Assembly High-level Meeting on Antimicrobial Resistance (UNGA HLM-AMR) committed to a target that 70% of global human antibiotic use (ABU) should be from the Access group of the WHO AWaRe system. MethodsWe used 2019 IQVIA MIDAS(R) global ABU Quarterly value sales, volumes (kg/SU) and average ex-manufacturer prices to evaluate price per daily defined dose (DDD) by AWaRe group across countries. IQVIA MIDAS volumes/value data reflect public, private, or mixed s...

3
Influence of microbial composition and sample type on antimicrobial resistance in urinary tract infections: a single-centre retrospective cohort study (2015-2023)
2026-03-02 infectious diseases 10.64898/2026.02.23.26344629
#1 (3.5%)
Show abstract

ObjectivesTo quantify how urine sample type and polymicrobial context impact antimicrobial resistance (AMR) in urinary tract infections (UTIs), using routine diagnostics at scale. MethodsIn this retrospective, single-centre study, we analysed 188,687 urine cultures from the Institute of Medical Microbiology, University of Zurich, Switzerland (January 2015 to May 2023). We compared midstream urine (MU), indwelling catheter (IDC), and intermittent catheter (IMC) samples. Samples were classified a...

4
Antibiotic price formulation in Tanzania: evidence from national regulatory import permit data 2010-2016
2026-03-06 pharmacology and therapeutics 10.64898/2026.03.05.26347741
Top 0.1% (2.0%)
Show abstract

Background Antibiotic pricing is a key determinant of access and stewardship in low- and middle-income countries (LMICs), yet empirical evidence on how prices are formed within pharmaceutical markets remains limited. However, there is little longitudinal evidence on how antibiotic prices behave within national pharmaceutical supply systems. This study evaluated the patterns and determinants of systemic antibiotic pricing in Tanzania using national regulatory import permit data. Methods We conduc...

5
Antibiotic coverage in biliary-stented pancreatoduodenectomy: Real-world evidence supporting piperacillin tazobactam over ampicillin sulbactam
2026-02-14 infectious diseases 10.64898/2026.02.12.26346173
Top 0.5% (1.2%)
Show abstract

BackgroundPreoperative biliary stenting alters biliary colonization and may reduce the effectiveness of perioperative antibiotic prophylaxis in pancreatoduodenectomy. Although broader-spectrum regimens have been associated with improved infectious outcomes, their microbiological adequacy in routine clinical practice remains poorly defined. We therefore evaluated the real-world adequacy of a prolonged ampicillin-sulbactam protocol, its association with infectious outcomes and survival, and the po...

6
Novel transposon Tn8026 acts as a global driver of transmissible linezolid resistance in Enterococcus via a linear plasmid
2026-03-04 infectious diseases 10.64898/2026.03.04.26347163
Top 0.5% (1.2%)
Show abstract

Linezolid is a critical last-resort antimicrobial for multidrug-resistant Enterococcus faecium, particularly against vancomycin-resistant lineages where therapeutic options are severely limited. While resistance has historically arisen through de novo chromosomal mutations, the global emergence of transferable resistance mechanisms threatens to render more infections untreatable. Here, we characterise a recent (2023-2024) hospital-associated outbreak of linezolid-resistant E. faecium in Queensla...

7
Genomic and clinical determinants of extraintestinal Clostridium perfringens infections in immunocompromised patients
2026-02-19 infectious diseases 10.64898/2026.02.18.26346578
Top 0.7% (0.9%)
Show abstract

BackgroundClostridium perfringens can cause life-threatening extraintestinal infections in immunocompromised patients, an area in which we have little information regarding strain factors that impact patient risks and outcomes. MethodsWe conducted genomic-epidemiologic analyses on C. perfringens isolates from 70 patients seen at Brigham and Womens Hospital over 2021-2024. Genomic analyses evaluated strain profiles within a broader context of 2,321 C. perfringens genomes from foodborne, veterina...

8
A Proof-of-Concept Study of a Clinical Decision Support System for Vancomycin Therapeutic Monitoring
2026-03-02 pharmacology and therapeutics 10.64898/2026.02.22.26346368
Top 0.8% (0.8%)
Show abstract

Artificial intelligence (AI), particularly large language models (LLMs), is increasingly explored in healthcare, yet its real-world usability and safety in high-risk clinical pharmacy tasks remain uncertain. Vancomycin therapeutic drug monitoring (TDM), which requires precise pharmacokinetic calculations and context-sensitive interpretation within a narrow therapeutic window, provides a stringent test case for AI-assisted decision support. This proof-of-concept study developed and evaluated a hy...

9
Mapping the Antimicrobial Susceptibility of Methicillin-Resistant Staphylococcus aureus in Western Ethiopia: A multicenter cross-sectional study
2026-03-06 infectious diseases 10.64898/2026.03.05.26347706
Top 1% (0.6%)
Show abstract

From 2021 to 2025, MRSA emerged as a major multidrug-resistant pathogen in the study area. Among 545 S. aureus isolates, 67.2% were MRSA, disproportionately affecting children under five (26.5%) and males (55.5%). Case incidence more than doubled by 2025, suggesting rising transmission or resistance. Most isolates were hospital-associated (85.2%), predominantly from outpatients (88.5%), with middle ear discharge as the main source (67%). Gentamicin showed the highest susceptibility (72.1%), whil...

10
Nephroprotective Effect of GLP-1 Receptor Agonists (GLP-1 RAs) in Patients Receiving Lithium Therapy: A Population-Based Study Using the TriNetX Network
2026-02-11 pharmacology and therapeutics 10.64898/2026.02.09.26345925
Top 1% (0.5%)
Show abstract

GLP-1 receptor agonists (GLP-1 RAs) are effective in delaying progression of chronic kidney disease in individuals with type 2 diabetes mellitus (T2DM). We evaluated whether GLP-1 RA prescription is associated with reduced nephrotoxicity in adults receiving long-term lithium therapy. We conducted a retrospective, propensity score-matched cohort study using electronic health records from the TriNetX global network, which includes de-identified data from over 127 million patients across 109 health...

11
Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy and Migraine
2026-03-02 pharmacology and therapeutics 10.64898/2026.02.26.26346744
Top 1% (0.5%)
Show abstract

Topiramate (TPM) is approved for seizures and migraine prophylaxis and is used off-label for several neuropsychiatric conditions. The available dosage forms, including tablets and sprinkle capsules, are unsuitable for patients who may be unable to take medicine orally. The resulting potential treatment interruptions could have untoward consequences and underscores the importance of developing a parenteral formulation. In this study, we developed a population pharmacokinetic model of a novel, int...

12
Biomedical Large Language Models and Prompt Engineering for Causality Assessment of Individual Case Safety Reports in Pharmacovigilance
2026-02-24 pharmacology and therapeutics 10.64898/2026.02.19.26346467
Top 1% (0.5%)
Show abstract

BackgroundBiomedical Large Language Models (LLMs) combined with prompt engineering offer domain-specific reasoning, yet their application to individual-level causality assessment remains unexplored. This study evaluated five combinations of biomedical LLMs, prompting strategies, and causality algorithms by comparing their agreement with two human expert evaluators. Research design and methodsA total of 150 Individual Case Safety Reports (ICSRs) were analyzed: 140 reports from Food and Drug Admi...

13
Comparative Analysis of Biofilm Formation in Bacterial and Fungal Isolates from Contact Lens and Non-Contact Lens Associated Keratitis
2026-02-09 infectious diseases 10.64898/2026.02.09.26345896
Top 1% (0.5%)
Show abstract

Microbial keratitis is a sight-threatening corneal infection with varying etiological agents, primarily bacteria and fungi. Assessing and contrasting the virulence factors of microorganisms isolated from a non-contact lens-associated keratitis (NCLAK) and contact lens-associated keratitis (CLAK) is the goal of the current investigation. Samples were collected from over 60 patients and analysed using standard microbiological techniques, including culture, Gram staining, KOH mount, biochemical tes...

14
HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya
2026-03-02 hiv aids 10.64898/2026.02.26.26347230
Top 2% (0.4%)
Show abstract

BackgroundMaintaining viral suppression among people who inject drugs (PWID) living with HIV in sub-Saharan Africa remains critical to minimize drug resistance for dolutegravir (DTG)-based regimens. We evaluated PWID taking DTG to assess longitudinal rates of viral non-suppression and emergence of drug resistance mutations in Kenya. MethodsWe enrolled Kenyan PWID who had transitioned from an efavirenz (EFV) based regimen to tenofovir+lamivudine+DTG (TLD) [≥]6 months prior, and measured plasm...

15
Prediction of Buruli ulcer treatment shortening with novel beta-lactam-containing antimicrobial combinations
2026-03-02 infectious diseases 10.64898/2026.02.28.26347324
Top 2% (0.4%)
Show abstract

IntroductionBuruli ulcer (BU) is a neglected tropical disease primarily affecting skin and sometimes bone. Standard therapy consists of rifampicin (RIF, once daily) plus clarithromycin (CLA, twice daily) over 8 weeks. Adding amoxicillin-clavulanate (AMX/CLV) may shorten treatment, but predicting treatment success before clinical trial implementation is challenging. AimsTo assess the probability of bacterial eradication following treatment with novel investigational BU regimens over different in...

16
Two-step deep-learning candidemia prediction model using two large time-sequence electronic health datasets
2026-03-04 infectious diseases 10.64898/2026.03.03.26347531
Top 2% (0.4%)
Show abstract

BackgroundCandidemia is a rare but life-threatening bloodstream infection that remains difficult to predict using conventional risk stratification approaches, highlighting the need for improved predictive strategies. As a result, empiric antifungal therapy is often delayed even in high-risk patients. MethodsWe developed a deep learning model (PyTorch_EHR) to predict 7-day candidemia risk by using electronic health record data from two large cohorts (Houston Methodist Hospital System [HMHS] and ...

17
Utilisation And Determinants Of Blood Culture In Managing Sepsis Among Hospitalised Children <5 Years: A Mixed-Method Study At Four Amr Surveillance Sites In Uganda, 2024-2025.
2026-03-04 infectious diseases 10.64898/2026.03.03.26347550
Top 2% (0.4%)
Show abstract

Sepsis caused by drug-resistant pathogens remains a major contributor to under-five mortality in low- and middle-income countries, threatening progress toward Sustainable Development Goal (SDG) 3.2. Blood culture, the gold standard for sepsis diagnosis and antimicrobial stewardship, remains underutilised in routine pediatric care. This study assessed the extent and determinants of blood culture utilisation among hospitalised children under five years with suspected sepsis at four antimicrobial r...

18
Multicentre validation and update of a Legionella prediction score to guide testing and treatment in community-acquired pneumonia
2026-02-27 infectious diseases 10.64898/2026.02.25.26347092
Top 3% (0.4%)
Show abstract

ObjectivesDiagnosis of community-acquired Legionnaires disease (CALD) relies on microbiological testing. Routine testing in hospitalised CAP patients has low positivity rates. We externally validated a Legionella prediction score, assessed its applicability in routine care, and explored potential updates. MethodsWe analysed data from 196 CALD patients from 20 Swiss hospitals and 196 Legionella-negative CAP controls matched by date of diagnosis ({+/-}14 days; August 2022-March 2024). We assessed...

19
Utilizing pharmacy refill data to predict loss to follow-up among people living with HIV in Manyara region of Tanzania
2026-02-26 hiv aids 10.64898/2026.02.24.26347034
Top 3% (0.3%)
Show abstract

BackgroundAchieving optimal adherence and retention in HIV care is essential for sustaining viral suppression. Pharmacy refill records offer an objective approach to assessing adherence in settings where routine viral load testing is limited. This study evaluated pharmacy refill adherence, loss to follow-up (LTFU), and their predictors among people living with HIV (PLHIV) in the Manyara region of Tanzania. MethodsWe conducted a retrospective cohort analysis of 22,650 PLHIV across five districts...

20
WHO early warning indicators of HIV drug resistance in children and adolescents living with HIV in Cameroon: a pre- and post-COVID-19 analysis
2026-02-14 hiv aids 10.64898/2026.02.10.26346049
Top 3% (0.3%)
Show abstract

COVID-19 disrupted global health service delivery, particularly among children and adolescents living with HIV (CALHIV), increasing the risk of poor treatment adherence. This study assessed the impact of the COVID-19 pandemic on WHO-recommended early warning indicators (EWIs) of HIV drug resistance (HIVDR) among CALHIV. We conducted a descriptive, longitudinal, retrospective study among children (0-9 years) and adolescents (10-19 years) receiving antiretroviral therapy (ART) in five health facil...